Cemex Posts Higher 4Q Operating Gains, Net Loss on Tax Provision
By Anthony Harrup
MEXICO CITY--Mexican cement maker Cemex posted double-digit sales and operating profit for the fourth quarter, while a $613 million tax provision led to a net loss for the period.
Monterrey-based Cemex, one of the world's largest building materials companies, said Thursday that its sales rose 10% from year-earlier quarter to $4.24 billion, driven by higher prices for its products in all regions where it operates.
Earnings before interest, taxes, depreciation and amortization, a measure of profitability, rose 18% to $743 million, supported by higher prices and easing cost inflation. Operating profit rose 20%.
Cemex reported a net loss for the October-December quarter of $441 million, or $0.30 an American depositary share, compared with a loss of $99 million a year earlier. The loss was the result of a provision made in the quarter related to a tax dispute in Spain.
Cemex's full-year sales rose 12% to $17.42 billion despite lower volumes for cement and ready-mix concrete, and Ebitda increased 25% to a record $3.45 billion. Full-year net profit was $182 million.
The company said it plans a quarterly dividend program, with $120 million to be distributed the first year starting in the second quarter.
For 2024, Cemex projects low-to-mid single-digit growth in Ebitda, and capital expenditures of $1.6 billion, including $1 billion for maintenance. The company expects cement sales volumes to be flat to slightly higher, and ready-mix and aggregates volumes flat to slightly lower.
Write to Anthony Harrup at anthony.harrup@wsj.com
(END) Dow Jones Newswires
February 08, 2024 08:51 ET (13:51 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks